Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Monoamine oxidase activity in different density gradient fractions of human platelets

  • 30 Accesses

  • 33 Citations

Abstract

Monoamine oxidase (MAO) activity measured in human platelets is reportedly altered by such drugs as epinephrine, lithium carbonate, and imipramine, and also reduced in a number of clinical disorders. To evaluate whether MAO activity might differ in platelet supopulations, density gradient centrifugation with arabino-galactan was used to prepare four platelet fractions that differed in weight and volume. MAO activity in the lightest and smallest platelet subpopulation was approximately one-half that in the heaviest and largest subpopulation. Because platelet weight and size are thought to be related to platelet age, it is possible that some drug effects on platelet MAO activity might represent changes in platelet turnover. Factors other than platelet turnover rates may contribute to individual differences in platelet MAO activity, however, since one group of individuals with markedly reduced platelet MAO activity exhibited no shift in the proportion of lighter versus heavier platelets nor in the relative amount of MAO activity in each density gradient subfraction.

This is a preview of subscription content, log in to check access.

References

  1. Amorosi, E., Garg, S. K., Karpatkin, S.: Heterogeneity of human platelets. IV. Identification of a young platelet population with Se75-selenomethionine. Br. J. Haematol. 21, 227–232 (1971)

  2. Bockar, J., Roth, R., Henninger, G.: Increased human platelet MAO during lithium carbonate therapy. Life Sci. 15, 2109–2118 (1974)

  3. Branehog, I., Weinfeld, A., Roos, B.: The exchangeable splenic platelet pool studied with epinephrine infusion in idiopathic thrombocytopenic purpura and patients with splenomegaly. Br. J. Haematol. 25, 239–248 (1973)

  4. Buchsbaum, M., Coursey, R. D., Murphy, D. L.: The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science 194, 339–341 (1976)

  5. Corash, L., Tan, H., Gralnick, H. R.: Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood 49, 71–87 (1977)

  6. Donnelly, C. H., Murphy, D. L.: Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem. Pharmacol. 26, 853–858 (1977)

  7. Gentil, V., Greenwood, M. H., Lader, M. H.: The effect of adrenaline on human platelet MAO. Psychopharmacologia (Berl.) 44, 187–194 (1975)

  8. George, J. N., Sears, D. A.: Platelet membrane fragmentation as a model for platelet aging. Clin. Res. 21, 554 (1973)

  9. Karpatkin, S.: Human platelet senescence. Annu. Rev. Med. 23, 101–128 (1972)

  10. Minter, F. M., Ingram, M.: Platelet volume: density relationships in normal and acutely bled dogs. Br. J. Haematol. 20, 55–68 (1971)

  11. Murphy, D. L., Belmaker, R., Carpenter, W. T., Wyatt, R. J.: Monoamine oxidase in chronic schizophrenia: studies of hormonal and other factors affecting enzyme activity. Br. J. Psychiatry 130, 151–158 (1977a)

  12. Murphy, D. L., Belmaker, R., Wyatt, R. J.: Monoamine oxidase in schizophrenia and other behavioral disorders. J. Psychiatr. Res. 11, 221–245 (1974)

  13. Murphy, D. L., Brand, E., Goldman, T., Baker, M., Wright, C., van Kammen, D., Gordon, E.: Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment. J. Nerv. Ment. Dis. 164, 129–134 (1977b)

  14. Murphy, D. L., Donnelly, C. H.: Monoamine oxidase in man: enzyme characteristics in platelets, plasma and other human tissues. In: Neuropsychopharmacology of monoamines and their regulatory enzymes, E. Usdin, ed., pp. 71–85. New York: Raven 1974

  15. Murphy, D. L., Donnelly, C. H., Miller, L., Wyatt, R. J.: Platelet monoamine oxidase in chronic schizophrenia: some enzyme characteristics relevant to reduced activity. Arch. Gen. Psychiatry 33, 1377–1381 (1976a)

  16. Murphy, D. L., Goodwin, F. K., Bunney, W. E., Jr.: Leukocytosis during lithium treatment. Am. J. Psychiatry 127, 1559–1561 (1971)

  17. Murphy, D. L., Redmond, D. E., Jr., Baulu, J., Donnelly, C. H.: Monoamine oxidase activity in 116 rhesus monkeys: relations between enzyme activity and age, sex and genetic factors. Comp. Biochem. Physiol. (in press, 1978)

  18. Murphy, D. L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L., Wyatt, R. J.: Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem. Med. 16, 254–265 (1976b)

  19. Murphy, D. L., Wyatt, R. J.: Enzyme studies in the major psychiatric disorders. I. Catechol-O-methyl-transferase, monoamine oxidase in the affective disorders, and factors affecting some behavior-related enzyme activities. In: The biology of the major psychoses: a comparative analysis, D. X. Freedman, ed., pp. 277–288. New York: Raven 1975

  20. Murphy, S., Oski, F. A., Naiman, J. L., Lusch, C. J., Goldberg, S., Gardner, F. H.: Platelet size and kinetics in hereditary and acquired thrombocytopenia. N. Engl. J. Med. 286, 499–504 (1972)

  21. Neff, N. H., Goridis, C.: Neuronal monoamine oxidases: specific enzyme types and their rates of formation. Adv. Biochem. Psychopharmacol. 5, 307–323 (1972)

  22. Nies, A., Robinson, D. S., Lamborn, K. R., Lampert, R. P.: Genetic control of platelet and plasma monoamine oxidase activity. Arch. Gen. Psychiatry 28, 834–838 (1973)

  23. Penington, D. G., Lee, N. L. Y., Roxburgh, A. E., McGready, J. R.: Platelet density and size: the interpretation of heterogeneity. Br. J. Haematol. 34, 365–376 (1976)

  24. Robinson, D. S., Nies, A., Ravaris, L., Lamborn, K. R.: The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states. Arch. Gen. Psychiatry 29, 409–413 (1973)

  25. Sullivan, J. L., Dackis, C., Stanfield, C.: In vivo inhibition of platelet MAO activity by tricyclic antidepressants. Am. J. Psychiatry 134, 188–190 (1977)

  26. Wolstenholme, G. E. W., Knight, J. (eds.): Monoamine oxidase and its inhibition. Ciba Foundation Symposium, 39. Amsterdam: Elsevier 1976

  27. Youdim, M. B. H., Woods, H. F., Mitchell, B., Sandler, M.: Human platelet MAO activity in iron-deficiency anaemia. Clin. Sci. Mol. Med. 48, 289–295 (1975)

Download references

Author information

Correspondence to Dennis L. Murphy.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Murphy, D.L., Costa, J.L., Shafer, B. et al. Monoamine oxidase activity in different density gradient fractions of human platelets. Psychopharmacology 59, 193–197 (1978). https://doi.org/10.1007/BF00427757

Download citation

Key words

  • Monoamine oxidase
  • Platelets
  • Density gradient